Pleomorphic adenoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 2: | Line 2: | ||
{{Pleomorphic adenoma}} | {{Pleomorphic adenoma}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{M.N}} | ||
==Overview== | ==Overview== | ||
The annual [[Incidence (epidemiology)|incidence]] of pleomorphic adenoma is approximately 2-3.5 cases per 100,000 [[population]]. It accounts for 45-75% of all [[salivary gland]] [[neoplasms]]. [[Females]] are more commonly affected than [[males]]. | The annual [[Incidence (epidemiology)|incidence]] of pleomorphic adenoma is approximately 2-3.5 cases per 100,000 [[population]]. It accounts for 45-75% of all [[salivary gland]] [[neoplasms]]. [[Females]] are more commonly affected than [[males]]. |
Revision as of 18:46, 28 January 2019
Pleomorphic adenoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pleomorphic adenoma epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Pleomorphic adenoma epidemiology and demographics |
Pleomorphic adenoma epidemiology and demographics in the news |
Risk calculators and risk factors for Pleomorphic adenoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maneesha Nandimandalam, M.B.B.S.[2]
Overview
The annual incidence of pleomorphic adenoma is approximately 2-3.5 cases per 100,000 population. It accounts for 45-75% of all salivary gland neoplasms. Females are more commonly affected than males.
Epidemiology and Demographics
Incidence
- The annual incidence of pleomorphic adenoma is approximately 2-3.5 cases per 100,000 population.[1]
- It accounts for 45-75% of all salivary gland neoplasms.
- Pleomorphic adenoma distribution among the salivary glands is as follows[2]:
- Parotid gland: 84%
- Submandibular gland: 8%
- Minor salivary glands: 6.5%
Age
- People of all age groups may develop pleomorphic adenoma.[1]
- The incidence of pleomorphic adenoma increases with age; the average age at diagnosis is 43-46 years.
Race
- There is no racial predilection to pleomorphic adenoma.
Gender
- Females are predominantly affected by pleomorphic adenoma than males. The female to male ratio is approximately (2:1)
References
- ↑ 1.0 1.1 Pinkston JA, Cole P (June 1999). "Incidence rates of salivary gland tumors: results from a population-based study". Otolaryngol Head Neck Surg. 120 (6): 834–40. doi:10.1016/S0194-5998(99)70323-2.
- ↑ Zhan KY, Khaja SF, Flack AB, Day TA (April 2016). "Benign Parotid Tumors". Otolaryngol. Clin. North Am. 49 (2): 327–42. doi:10.1016/j.otc.2015.10.005. PMID 27040584.